Entertainment Earth, Inc. partners with IVEST Consumer Partners
Entertainment Earth, Inc. (EE) has established a partnership with private equity firm IVEST Consumer Partners.
Entertainment Earth is one of the largest and longest-operating specialty distributors and online retailers of licensed merchandise and entertainment-based collectibles, action figures, toys, bobbleheads and other enthusiast and trend products. As a top online seller focused on these categories, EE serves as a critical link between the vast and growing marketplace of intellectual property creators, consumer product brands that secure licenses to use intellectual property “themes” for their toys and the demanding collectors and consumers who seek out EE and other specialty retailers for access to the hottest new products.
Founded in 2013 in Vancouver, Canada, IVEST Consumer Partners seeks investments in well-run private companies that can leverage its world-class operational track record.
Oaklins Intrepid in Los Angeles acted as sell-side advisor.
Talk to the deal team
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more